Efficacy, safety and clinical outcomes of Paritaprevir/Ombitasvir/r + Dasabuvir 8 weeks: results from a Spanish real world cohort (Hepa-C) M. Puigvehí, B.D. Cuenca, D. Giménez, F. Gea, M. Diago, S. Lens, E. Badia-Aranda, J. Turnés, A.O. Martin,J. Salmerón, J.M. Pascasio, J.L.C. Urda, J.L.C. Panero, J. Cabezas, X. Torras, E. Molina, J.M. Moreno, J. Sánchez-Ruano,J. De la Vega, S. MontoliuJournal of Hepatology（2018）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
